---
layout: default
title: Thin Bridges for Drug Text Alignment: Lightweight Contrastive Learning for Target Specific Drug Retrieval
---

# Thin Bridges for Drug Text Alignment: Lightweight Contrastive Learning for Target Specific Drug Retrieval

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2510.03309" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2510.03309v1</a>
  <a href="https://arxiv.org/pdf/2510.03309.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2510.03309v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2510.03309v1', 'Thin Bridges for Drug Text Alignment: Lightweight Contrastive Learning for Target Specific Drug Retrieval')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Mallikarjuna Tupakula

**åˆ†ç±»**: cs.LG, q-bio.BM

**å‘å¸ƒæ—¥æœŸ**: 2025-09-30

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºè½»é‡çº§å¯¹æ¯”å­¦ä¹ æ¡¥æ¥æ–¹æ³•ï¼Œç”¨äºé¶ç‚¹ç‰¹å¼‚æ€§è¯ç‰©æ–‡æœ¬å¯¹é½ä¸æ£€ç´¢ã€‚**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±äºŒï¼šRLç®—æ³•ä¸æ¶æ„ (RL & Architecture)** **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `è¯ç‰©å‘ç°` `å¯¹æ¯”å­¦ä¹ ` `å¤šæ¨¡æ€å¯¹é½` `é¶ç‚¹ç‰¹å¼‚æ€§æ£€ç´¢` `åŒ–å­¦ä¿¡æ¯å­¦`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰è¯ç‰©å‘ç°æ–¹æ³•ä¾èµ–å¤§è§„æ¨¡å¤šæ¨¡æ€è¯­æ–™åº“æˆ–ç¹é‡é¢„è®­ç»ƒï¼Œè®¡ç®—æˆæœ¬é«˜æ˜‚ã€‚
2. æå‡ºè½»é‡çº§å¯¹æ¯”æ¡¥æ¥æ–¹æ³•ï¼Œé€šè¿‡çº¿æ€§æŠ•å½±å¤´å¯¹é½åŒ–å­¦å’Œæ–‡æœ¬è¡¨ç¤ºï¼Œæ— éœ€è®­ç»ƒå®Œæ•´å¤šæ¨¡æ€æ¨¡å‹ã€‚
3. å®éªŒè¡¨æ˜ï¼Œè¯¥æ–¹æ³•åœ¨éª¨æ¶åˆ†å‰²ä¸‹æ˜¾è‘—æé«˜äº†é¶ç‚¹å†…çš„åŒºåˆ†èƒ½åŠ›ï¼Œä¼˜äºå†»ç»“çš„åŸºçº¿æ¨¡å‹ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

å¤šæ¨¡æ€åŸºç¡€æ¨¡å‹åœ¨è¯ç‰©å‘ç°å’Œç”Ÿç‰©åŒ»å­¦åº”ç”¨ä¸­å±•ç°å‡ºæ½œåŠ›ï¼Œä½†ç°æœ‰æ–¹æ³•é€šå¸¸ä¾èµ–äºå¤§è§„æ¨¡å¤šæ¨¡æ€è¯­æ–™åº“æˆ–ç¹é‡çš„é¢„è®­ç»ƒã€‚æœ¬æ–‡ç ”ç©¶äº†è½»é‡çº§å¯¹æ¯”æ¡¥æ¥æ–¹æ³•ï¼Œå³åœ¨å†»ç»“çš„å•æ¨¡æ€ç¼–ç å™¨ä¸Šä½¿ç”¨è½»é‡çº§æŠ•å½±å¤´ï¼Œèƒ½å¦åœ¨ä¸è®­ç»ƒå®Œæ•´å¤šæ¨¡æ€æ¨¡å‹çš„æƒ…å†µä¸‹å¯¹é½åŒ–å­¦å’Œæ–‡æœ¬è¡¨ç¤ºã€‚é€šè¿‡ä½¿ç”¨ChEMBLä¸­çš„é…å¯¹æœºåˆ¶ï¼Œæˆ‘ä»¬åˆ©ç”¨åŒçº¿æ€§æŠ•å½±å’Œå¯¹æ¯”ç›®æ ‡å‡½æ•°ï¼Œå°†ECFP4åˆ†å­æŒ‡çº¹ä¸ç”Ÿç‰©åŒ»å­¦å¥å­åµŒå…¥å¯¹é½ã€‚ä¸ºäº†æ›´å¥½åœ°å¤„ç†å…±äº«ç›¸åŒæ²»ç–—é¶ç‚¹çš„è¯ç‰©ï¼Œæˆ‘ä»¬å¼•å…¥äº†éš¾è´Ÿæ ·æœ¬åŠ æƒå’Œmargin lossã€‚åŸºäºéª¨æ¶åˆ†å‰²çš„è¯„ä¼°ï¼ˆéœ€è¦è·¨ä¸ç›¸äº¤åŒ–å­¦æ ¸å¿ƒçš„æ³›åŒ–ï¼‰è¡¨æ˜ï¼Œæˆ‘ä»¬çš„æ–¹æ³•å®ç°äº†éå¹³å‡¡çš„è·¨æ¨¡æ€å¯¹é½ï¼Œå¹¶æ˜¾è‘—æé«˜äº†é¶ç‚¹å†…çš„åŒºåˆ†èƒ½åŠ›ï¼Œä¼˜äºå†»ç»“çš„åŸºçº¿æ¨¡å‹ã€‚è¿™äº›ç»“æœè¡¨æ˜ï¼Œè½»é‡çº§æ¡¥æ¥æ–¹æ³•ä¸ºå¤§è§„æ¨¡å¤šæ¨¡æ€é¢„è®­ç»ƒæä¾›äº†ä¸€ç§è®¡ç®—é«˜æ•ˆçš„æ›¿ä»£æ–¹æ¡ˆï¼Œä»è€Œèƒ½å¤Ÿåœ¨ç²¾å‡†åŒ»å­¦ä¸­å®ç°éª¨æ¶æ„ŸçŸ¥çš„è¯ç‰©æ–‡æœ¬å¯¹é½å’Œé¶ç‚¹ç‰¹å¼‚æ€§æ£€ç´¢ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šè®ºæ–‡æ—¨åœ¨è§£å†³è¯ç‰©å‘ç°é¢†åŸŸä¸­ï¼Œå¦‚ä½•é«˜æ•ˆåœ°å¯¹é½è¯ç‰©çš„åŒ–å­¦ç»“æ„è¡¨ç¤ºå’Œæ–‡æœ¬æè¿°è¡¨ç¤ºï¼Œä»è€Œå®ç°é¶ç‚¹ç‰¹å¼‚æ€§çš„è¯ç‰©æ£€ç´¢ã€‚ç°æœ‰æ–¹æ³•é€šå¸¸ä¾èµ–äºå¤§è§„æ¨¡å¤šæ¨¡æ€é¢„è®­ç»ƒï¼Œè®¡ç®—æˆæœ¬é«˜æ˜‚ï¼Œä¸”éš¾ä»¥æ³›åŒ–åˆ°æ–°çš„åŒ–å­¦éª¨æ¶ä¸Šã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡çš„æ ¸å¿ƒæ€è·¯æ˜¯åˆ©ç”¨è½»é‡çº§çš„å¯¹æ¯”å­¦ä¹ æ¡¥æ¥æ–¹æ³•ï¼Œåœ¨é¢„è®­ç»ƒå¥½çš„å•æ¨¡æ€ç¼–ç å™¨ï¼ˆä¾‹å¦‚ï¼Œç”¨äºåˆ†å­æŒ‡çº¹çš„ECFP4å’Œç”¨äºæ–‡æœ¬çš„ç”Ÿç‰©åŒ»å­¦å¥å­åµŒå…¥ï¼‰ä¹‹ä¸Šï¼Œæ·»åŠ å¯è®­ç»ƒçš„çº¿æ€§æŠ•å½±å¤´ã€‚é€šè¿‡å¯¹æ¯”å­¦ä¹ çš„ç›®æ ‡å‡½æ•°ï¼Œå°†åŒ–å­¦ç»“æ„å’Œæ–‡æœ¬æè¿°æ˜ å°„åˆ°åŒä¸€ä¸ªåµŒå…¥ç©ºé—´ï¼Œä»è€Œå®ç°è·¨æ¨¡æ€çš„å¯¹é½ã€‚è¿™ç§æ–¹æ³•é¿å…äº†ä»å¤´å¼€å§‹è®­ç»ƒå¤§å‹å¤šæ¨¡æ€æ¨¡å‹ï¼Œå¤§å¤§é™ä½äº†è®¡ç®—æˆæœ¬ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šæ•´ä½“æ¡†æ¶åŒ…å«ä»¥ä¸‹å‡ ä¸ªä¸»è¦æ¨¡å—ï¼š1) å•æ¨¡æ€ç¼–ç å™¨ï¼šä½¿ç”¨é¢„è®­ç»ƒå¥½çš„ECFP4ï¼ˆExtended Connectivity Fingerprintsï¼‰ä½œä¸ºåˆ†å­æŒ‡çº¹ç¼–ç å™¨ï¼Œä»¥åŠé¢„è®­ç»ƒå¥½çš„ç”Ÿç‰©åŒ»å­¦å¥å­åµŒå…¥æ¨¡å‹ä½œä¸ºæ–‡æœ¬ç¼–ç å™¨ã€‚è¿™ä¸¤ä¸ªç¼–ç å™¨åœ¨è®­ç»ƒè¿‡ç¨‹ä¸­è¢«å†»ç»“ã€‚2) çº¿æ€§æŠ•å½±å¤´ï¼šåœ¨æ¯ä¸ªç¼–ç å™¨çš„è¾“å‡ºä¹‹ä¸Šæ·»åŠ ä¸€ä¸ªçº¿æ€§æŠ•å½±å±‚ï¼Œå°†ç¼–ç åçš„ç‰¹å¾æ˜ å°„åˆ°åŒä¸€ä¸ªä½ç»´åµŒå…¥ç©ºé—´ã€‚3) å¯¹æ¯”å­¦ä¹ ç›®æ ‡å‡½æ•°ï¼šä½¿ç”¨å¯¹æ¯”å­¦ä¹ çš„ç›®æ ‡å‡½æ•°ï¼Œä¾‹å¦‚InfoNCE lossï¼Œæ¥è®­ç»ƒçº¿æ€§æŠ•å½±å¤´ï¼Œä½¿å¾—åŒ¹é…çš„åŒ–å­¦ç»“æ„å’Œæ–‡æœ¬æè¿°åœ¨åµŒå…¥ç©ºé—´ä¸­è·ç¦»æ›´è¿‘ï¼Œè€Œä¸åŒ¹é…çš„æ ·æœ¬è·ç¦»æ›´è¿œã€‚4) éš¾è´Ÿæ ·æœ¬åŠ æƒå’ŒMargin Lossï¼šä¸ºäº†æ›´å¥½åœ°å¤„ç†å…±äº«ç›¸åŒæ²»ç–—é¶ç‚¹çš„è¯ç‰©ï¼Œå¼•å…¥äº†éš¾è´Ÿæ ·æœ¬åŠ æƒå’Œmargin lossï¼Œä»¥å¢å¼ºæ¨¡å‹åŒºåˆ†ç›¸ä¼¼è¯ç‰©çš„èƒ½åŠ›ã€‚

**å…³é”®åˆ›æ–°**ï¼šè®ºæ–‡çš„å…³é”®åˆ›æ–°åœ¨äºæå‡ºäº†è½»é‡çº§çš„å¯¹æ¯”å­¦ä¹ æ¡¥æ¥æ–¹æ³•ï¼Œè¯¥æ–¹æ³•å¯ä»¥åœ¨ä¸è®­ç»ƒå¤§å‹å¤šæ¨¡æ€æ¨¡å‹çš„æƒ…å†µä¸‹ï¼Œå®ç°è·¨æ¨¡æ€çš„è¯ç‰©æ–‡æœ¬å¯¹é½ã€‚æ­¤å¤–ï¼Œå¼•å…¥äº†éš¾è´Ÿæ ·æœ¬åŠ æƒå’Œmargin lossï¼Œè¿›ä¸€æ­¥æé«˜äº†æ¨¡å‹åœ¨é¶ç‚¹ç‰¹å¼‚æ€§æ£€ç´¢ä»»åŠ¡ä¸­çš„æ€§èƒ½ã€‚ä¸ç°æœ‰æ–¹æ³•ç›¸æ¯”ï¼Œè¯¥æ–¹æ³•è®¡ç®—æ•ˆç‡æ›´é«˜ï¼Œä¸”æ›´æ˜“äºæ³›åŒ–åˆ°æ–°çš„åŒ–å­¦éª¨æ¶ä¸Šã€‚

**å…³é”®è®¾è®¡**ï¼šå…³é”®è®¾è®¡åŒ…æ‹¬ï¼š1) ä½¿ç”¨çº¿æ€§æŠ•å½±å¤´ä½œä¸ºæ¡¥æ¥æ¨¡å—ï¼Œé™ä½äº†è®¡ç®—å¤æ‚åº¦ã€‚2) é‡‡ç”¨å¯¹æ¯”å­¦ä¹ çš„ç›®æ ‡å‡½æ•°ï¼Œé¼“åŠ±åŒ¹é…çš„æ ·æœ¬åœ¨åµŒå…¥ç©ºé—´ä¸­æ›´æ¥è¿‘ã€‚3) å¼•å…¥éš¾è´Ÿæ ·æœ¬åŠ æƒï¼Œå¯¹ä¸æ­£æ ·æœ¬ç›¸ä¼¼çš„è´Ÿæ ·æœ¬èµ‹äºˆæ›´é«˜çš„æƒé‡ï¼Œä»è€Œæé«˜æ¨¡å‹çš„åŒºåˆ†èƒ½åŠ›ã€‚4) ä½¿ç”¨Margin Lossï¼Œè¿›ä¸€æ­¥æ‹‰å¼€æ­£è´Ÿæ ·æœ¬ä¹‹é—´çš„è·ç¦»ï¼Œæé«˜æ¨¡å‹çš„é²æ£’æ€§ã€‚å…·ä½“çš„å‚æ•°è®¾ç½®å’Œç½‘ç»œç»“æ„ç»†èŠ‚åœ¨è®ºæ–‡ä¸­è¿›è¡Œäº†è¯¦ç»†æè¿°ï¼ˆæœªçŸ¥ï¼‰ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœè¡¨æ˜ï¼Œè¯¥æ–¹æ³•åœ¨åŸºäºéª¨æ¶åˆ†å‰²çš„è¯„ä¼°ä¸­ï¼Œæ˜¾è‘—æé«˜äº†é¶ç‚¹å†…çš„åŒºåˆ†èƒ½åŠ›ï¼Œä¼˜äºå†»ç»“çš„åŸºçº¿æ¨¡å‹ã€‚è¿™è¡¨æ˜è¯¥æ–¹æ³•èƒ½å¤Ÿæœ‰æ•ˆåœ°æ³›åŒ–åˆ°æ–°çš„åŒ–å­¦éª¨æ¶ä¸Šï¼Œå¹¶å®ç°éå¹³å‡¡çš„è·¨æ¨¡æ€å¯¹é½ã€‚å…·ä½“çš„æ€§èƒ½æå‡æ•°æ®åœ¨è®ºæ–‡ä¸­è¿›è¡Œäº†è¯¦ç»†æè¿°ï¼ˆæœªçŸ¥ï¼‰ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶æˆæœå¯åº”ç”¨äºè¯ç‰©å‘ç°ã€è¯ç‰©é‡å®šä½ã€ç²¾å‡†åŒ»å­¦ç­‰é¢†åŸŸã€‚é€šè¿‡å¯¹é½è¯ç‰©çš„åŒ–å­¦ç»“æ„å’Œæ–‡æœ¬æè¿°ï¼Œå¯ä»¥æ›´æœ‰æ•ˆåœ°è¿›è¡Œé¶ç‚¹ç‰¹å¼‚æ€§è¯ç‰©æ£€ç´¢ï¼ŒåŠ é€Ÿæ–°è¯ç ”å‘è¿›ç¨‹ã€‚æ­¤å¤–ï¼Œè¯¥æ–¹æ³•è¿˜å¯ä»¥ç”¨äºæ„å»ºè¯ç‰©çŸ¥è¯†å›¾è°±ï¼Œä¸ºè¯ç‰©ç ”ç©¶æä¾›æ›´å…¨é¢çš„ä¿¡æ¯æ”¯æŒï¼Œå¹¶è¾…åŠ©åŒ»ç”Ÿè¿›è¡Œä¸ªæ€§åŒ–æ²»ç–—æ–¹æ¡ˆçš„åˆ¶å®šã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Multimodal foundation models hold promise for drug discovery and biomedical applications, but most existing approaches rely on heavy pretraining or large scale multimodal corpora. We investigate whether thin contrastive bridges, lightweight projection heads over frozen unimodal encoders can align chemical and textual representations without training a full multimodal model. Using paired mechanisms from ChEMBL, we align ECFP4 molecular fingerprints with biomedical sentence embeddings through dual linear projections trained with a contrastive objective. To better handle drugs sharing the same therapeutic target, we incorporate hard negative weighting and a margin loss. Evaluation under scaffold based splits, which require generalization across disjoint chemical cores, demonstrates that our approach achieves non-trivial cross modal alignment and substantially improves within target discrimination compared to frozen baselines. These results suggest that thin bridges offer a compute efficient alternative to large scale multimodal pretraining, enabling scaffold aware drug text alignment and target specific retrieval in precision medicine.

